Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …

STRUCTURE OF THE GUIDELINES The original guidelines described the management of
oesophageal and gastric cancer within existing practice. This paper updates the guidance to …

The CONSORT (Consolidated Standards of Reporting Trials) Statement aims to improve the
reporting of randomized controlled trials (RCTs); however, it lacks guidance on the reporting …

Background Surgical resection is regarded as the only curative option for resectable
oesophageal cancer, but pulmonary complications occurring in more than half of patients …

Background Pelvic lymph node dissection (PLND) is the most reliable procedure for lymph
node staging. However, the therapeutic benefit remains unproven; although most radical …

The aim of evidence-based medicine is to improve the quality of health care by integrating
the best research evidence with clinical expertise and patient values. Evidence-based …

Objective: This review summarizes reporting of complications of esophageal cancer surgery.
Background: Accurate assessment of morbidity and mortality after surgery for cancer is …

Background The minimally invasive esophagectomy (MIE) is widely being implemented for
esophageal cancer in order to reduce morbidity and improve quality of life. Non‐randomized …

Purpose To evaluate the effect of major postoperative complications on health-related
quality of life (HRQL) in 5-year survivors of esophageal cancer surgery. Patients and …

Background Synthesis of patient-reported outcome (PRO) data is hindered by the range of
available PRO measures (PROMs) composed of multiple scales and single items with …